ArticleAntibody therapeutics2024

Leveraging high-throughput analytics and automation to rapidly develop high-concentration mAb formulations: integrated excipient compatibility and viscosity screening.

Lun Xin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.